Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice

Authors:
  • MVMaud N. Vissers
    Maud N. Vissers
  • CRCindy P. van Roomen
    Cindy P. van Roomen
  • JVJelske N. van der Veen
    Jelske N. van der Veen
  • CVCarlos L.J. Vrins
    Carlos L.J. Vrins
  • CKCindy Kunne
    Cindy Kunne
  • FSFrans Stellaard
    Frans Stellaard
  • JKJohn J.P. Kastelein
    John J.P. Kastelein
  • AGAlbert K. Groen
    Albert K. Groen

Abstract
Ezetimibe stimulates faecal neutral sterol (FNS) excretion in mice, which cannot be explained by cholesterol absorption inhibition alone. We investigated whether these effects are mediated via the sterol exporter ATP binding cassette transporter G8 (abcg8). Ezetimibe increased FNS excretion 2.7‐fold in WT mice and 1.5‐fold in abcg8−/− mice, without affecting biliary cholesterol secretion. Daily FNS excretion exceeded the sum of dietary cholesterol intake and biliary secretion by about 60%. Ezetimibe enhanced this ‘extra’ FNS excretion by 3.5‐fold and 1.5‐fold in wildtype (WT) and abcg8−/− mice, respectively. Ezetimibe stimulates fecal sterol excretion of non‐biliary and non‐dietary origin, probably through stimulation of trans‐intestinal cholesterol excretion. We show that this effect depends on intact abcg8 function.

This publication has 32 references indexed in Scilit: